Cancer Fighting Fish: Source of New Drugs?

  • Author: Melania Tesio
  • Published: 29 March 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Proceedings of the National Academy of Sciences/National Academy of Sciences
thumbnail image: Cancer Fighting Fish: Source of New Drugs?

During the process known as metastasis, cancer cells detach from the bulk of the tumor and colonize distant organs. In order to do so, they enter the blood circulation by attaching to the cells that constitute tumor vessels. This event is driven by interactions occurring between Galβ1–3GalNAcα1-Ser/Thr, a disaccharide present on the surface of tumor cells, and galectin-3, a protein situated on vascular cells.

Prasun Guha and colleagues, University of Maryland, USA, discovered that the commercial fish Pacific cod contains a glycopeptide which can bind galectin-3 with high affinity and, thus, prevent it from interacting with the disaccharide. When purified and tested in mice, this peptide, designated as TF100, blocked the ability of pancreatic cancer cells to dock to vascular cells and, consequently, to metastasize.

TF100 could, therefore, be used as an anticancer food supplement.

Article Views: 2872

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permisson guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH